Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 3Recruiting 2Terminated 1Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 2Gynecologic 1CNS 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 3Urogenital Neoplasms 2Pancreatic Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colorectal Neoplasms 2Brain Neoplasms 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Wilms Tumor 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Kidney Neoplasms 1Hot Flashes 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Dyslexia 1Digestive System Neoplasms 1Depression 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Advanced Malignant Neoplasm 1

Interventions

Docetaxel 158Prednisone 131Leuprolide 95bicalutamide 86enzalutamide 83Radiotherapy 80Goserelin 80Abiraterone Acetate 76acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 54Magnetic Resonance Spectroscopy 46Zoledronic Acid 44gallium 68 PSMA-11 37Flutamide 34abiraterone 32Estramustine 32radium Ra 223 dichloride 30apalutamide 27Surveys and Questionnaires 26Gonadotropin-Releasing Hormone 26Androgen Antagonists 25cabazitaxel 24Radiosurgery 24Dutasteride 22sipuleucel-T 21Prednisolone 21Triptorelin Pamoate 20Paclitaxel 20luprolide acetate gel depot 19Radiation 19Exercise 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Prostatic Neoplasms × Genetic Testing × Clear all
NCT04447703 2025-12-02

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Thomas Jefferson University

Phase NA Completed
346 enrolled
Genitourinary

Prostatic Neoplasms

NCT03934606 2025-04-10

Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model

Abramson Cancer Center at Penn Medicine

Completed
1,488 enrolled
GastrointestinalGenitourinary

Pancreatic Neoplasms, Prostatic Neoplasms, Genetic Predisposition to Disease

NCT04067960 2024-08-14

Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer

Mayo Clinic

Phase EARLY_PHASE1 Completed
197 enrolled
CNSGastrointestinalGenitourinaryGynecologic

Brain Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡